SRY and cancer: In addition to CD44, Nanog Homeobox (Nanog), SRY (Sex Determining Region Y)-Box 2 (SOX2), and Octamer-Binding Transcription Factor 4 (Oct4) play crucial roles in maintaining cancer stemness progression and the poor prognoses in cancer patients [13].